Back to Search
Start Over
Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
- Source :
- International Journal of COPD; Jan2024, Vol. 19, p97-110, 14p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 11769106
- Volume :
- 19
- Database :
- Complementary Index
- Journal :
- International Journal of COPD
- Publication Type :
- Academic Journal
- Accession number :
- 175262436
- Full Text :
- https://doi.org/10.2147/COPD.S424497